Clare Arnott's Publications
About Clare Arnott's Publications
Co-Director, Cardiovascular Program- Co-Director, Global Chronic & Complex Diseases
- BMed Sci,
- MBBS (Hons),
- PhD,
- FRACP,
- FESC,
- CF
-
Association Between Circulating GDF-15 and Cardio-Renal Outcomes and Effect of Canagliflozin: Results From the CANVAS Trial
Journal of the American Heart Association Date published: -
Heart Failure with Reduced Ejection Fraction-Does Sex Matter?
Current Heart Failure Reports Date published: -
Heart Failure Therapies for the Prevention of HER2-Monoclonal Antibody-Mediated Cardiotoxicity: A Systematic Review and Meta-Analysis of Randomized Trials
Cancers Date published: -
The Role of Sodium Glucose Cotransporter-2 Inhibitors in Atherosclerotic Cardiovascular Disease: A Narrative Review of Potential Mechanisms
Cells Date published: -
Effects of canagliflozin on hyperkalaemia and serum potassium in people with diabetes and chronic kidney disease: insights from the CREDENCE trial
Date published: -
Effects of canagliflozin on hyperkalaemia and serum potassium in people with diabetes and chronic kidney disease: insights from the CREDENCE trial
European Heart Journal Date published: -
Procedural Volumes in the Era of COVID: The Risk Versus Benefit Trade-Off
Heart, Lung and Circulation Date published: -
Effects of canagliflozin compared with placebo on major adverse cardiovascular and kidney events in patient groups with different baseline levels of HbA1c, disease duration and treatment intensity: results from the CANVAS Program
Diabetologia Date published: -
Effects of canagliflozin on serum potassium in people with diabetes and chronic kidney disease: the CREDENCE trial
European Heart Journal Date published: -
Effects of the SGLT2 inhibitor canagliflozin on plasma biomarkers TNFR-1, TNFR-2 and KIM-1 in the CANVAS trial
Diabetologia Date published: -
Sex Disparities in Sudden Cardiac Death
Circulation: Arrhythmia and Electrophysiology Date published: -
Guideline-Directed Medical Therapy in Females with Heart Failure with Reduced Ejection Fraction
Current Heart Failure Reports Date published: -
Association of Baseline Diuretic Use With Cardiovascular Outcomes in Patients With Heart Failure With Preserved Ejection Fraction: A Secondary Analysis From TOPCAT
Journal of Cardiac Failure Date published: -
Effects of a reduced-sodium added-potassium salt substitute on blood pressure in rural Indian hypertensive patients: a randomized, double-blind, controlled trial
The American Journal of Clinical Nutrition Date published: -
Why Are We Forgetting Patients With Peripheral Arterial Disease?
Heart, Lung and Circulation Date published: -
Blood Pressure Effects of Canagliflozin and Clinical Outcomes in Type 2 Diabetes and Chronic Kidney Disease
Circulation Date published: